|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Capitalization1 |
196 548 | 197 469 | 214 715 | 215 682 | 196 476 | 193 025 | - | - |
Enterprise Value (EV)2 |
215 548 | 213 669 | 230 615 | 240 182 | 204 667 | 200 853 | 198 640 | 194 624 |
P/E ratio |
25,7x | 15,7x | 30,4x | 26,7x | 8,20x | 20,3x | 17,7x | 16,6x |
Yield |
3,51% | 3,34% | 3,19% | 3,56% | 3,83% | 3,74% | 3,88% | 4,00% |
Capitalization / Revenue |
4,00x | 3,80x | 4,53x | 4,43x | 3,81x | 3,65x | 3,53x | 3,45x |
EV / Revenue |
4,39x | 4,12x | 4,86x | 4,94x | 3,96x | 3,80x | 3,63x | 3,48x |
EV / EBITDA |
14,9x | 13,7x | 14,6x | 14,3x | 11,2x | 11,0x | 10,4x | 9,80x |
Price to Book |
2,64x | 2,51x | 3,87x | 3,78x | 2,90x | 3,08x | 3,08x | 2,95x |
Nbr of stocks (in thousands) |
2 327 340 | 2 309 973 | 2 264 608 | 2 274 506 | 2 237 092 | 2 171 940 | - | - |
Reference price (USD) |
84,5 | 85,5 | 94,8 | 94,8 | 87,8 | 88,9 | 88,9 | 88,9 |
Announcement Date |
01/24/2018 | 01/30/2019 | 01/29/2020 | 01/26/2021 | 02/02/2022 | - | - | - |
1 CHF in Million 2 USD in Million |
|
|
Income Statement Evolution (Annual data) |
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net sales1 |
49 109 | 51 900 | 47 445 | 48 659 | 51 626 | 52 853 | 54 654 | 55 910 |
EBITDA1 |
14 492 | 15 646 | 15 809 | 16 845 | 18 246 | 18 192 | 19 181 | 19 853 |
Operating profit (EBIT)1 |
12 850 | 13 823 | 14 112 | 15 416 | 16 588 | 16 986 | 18 306 | 19 095 |
Operating Margin |
26,2% | 26,6% | 29,7% | 31,7% | 32,1% | 32,1% | 33,5% | 34,2% |
Pre-Tax Profit (EBT)1 |
8 999 | 13 835 | 8 940 | 9 878 | 26 137 | 11 475 | 12 904 | 13 636 |
Net income1 |
7 703 | 12 611 | 7 147 | 8 072 | 24 021 | 9 325 | 10 338 | 10 745 |
Net margin |
15,7% | 24,3% | 15,1% | 16,6% | 46,5% | 17,6% | 18,9% | 19,2% |
EPS2 |
3,28 | 5,44 | 3,12 | 3,55 | 10,7 | 4,39 | 5,03 | 5,36 |
Dividend per Share2 |
2,97 | 2,85 | 3,02 | 3,38 | 3,36 | 3,32 | 3,44 | 3,55 |
Announcement Date |
01/24/2018 | 01/30/2019 | 01/29/2020 | 01/26/2021 | 02/02/2022 | - | - | - |
1 USD in Million 2 USD |
|
|
Income Statement Evolution (Quarterly data) |
|
Fiscal Period: December
|
2019 Q4 |
2020 Q1 |
2020 Q2 |
2020 Q3 |
2020 Q4 |
2021 Q1 |
2021 Q2 |
2021 Q3 |
2021 Q4 |
2022 Q1 |
2022 Q2 |
2022 Q3 |
2022 Q4 |
2023 Q1 |
2023 Q2 |
Net sales1 |
12 403 | 12 283 | 11 347 | 12 259 | 12 770 | 12 411 | 12 956 | 13 030 | 13 229 | 12 531 | 12 925 | 13 179 | 13 665 | 13 408 | 13 573 |
EBITDA1 |
3 909 | 4 672 | 3 922 | 4 370 | 3 881 | 4 267 | 4 819 | 4 871 | 4 274 | - | 4 562 | 4 591 | 4 752 | - | - |
Operating profit (EBIT)1 |
3 462 | 4 177 | 3 669 | 4 069 | 3 501 | 3 957 | 4 345 | 4 467 | 3 819 | 4 083 | 4 303 | 4 432 | 4 164 | 4 375 | 4 535 |
Operating Margin |
27,9% | 34,0% | 32,3% | 33,2% | 27,4% | 31,9% | 33,5% | 34,3% | 28,9% | 32,6% | 33,3% | 33,6% | 30,5% | 32,6% | 33,4% |
Pre-Tax Profit (EBT) |
1 759 | 2 621 | 2 288 | 2 410 | 2 559 | 2 450 | 3 506 | 3 230 | 16 951 | 2 669 | - | - | - | - | - |
Net income1 |
1 129 | 2 173 | 1 867 | 1 935 | 2 094 | 2 059 | 2 895 | 2 758 | 16 308 | 2 222 | 2 475 | 2 607 | 2 365 | - | - |
Net margin |
9,10% | 17,7% | 16,5% | 15,8% | 16,4% | 16,6% | 22,3% | 21,2% | 123% | 17,7% | 19,2% | 19,8% | 17,3% | - | - |
EPS2 |
0,50 | 0,96 | 0,82 | 0,85 | 0,92 | 0,91 | 1,29 | 1,23 | 7,29 | 1,00 | 1,12 | 1,17 | 1,15 | - | - |
Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date |
01/29/2020 | 04/28/2020 | 07/21/2020 | 10/27/2020 | 01/26/2021 | 04/27/2021 | 07/21/2021 | 10/26/2021 | 02/02/2022 | 04/26/2022 | - | - | - | - | - |
1 USD in Million 2 USD |
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net Debt1 |
19 000 | 16 200 | 15 900 | 24 500 | 8 191 | 7 828 | 5 615 | 1 599 |
Net Cash position1 |
- | - | - | - | - | - | - | - |
Leverage (Debt / EBITDA) |
1,31x | 1,04x | 1,01x | 1,45x | 0,45x | 0,43x | 0,29x | 0,08x |
Free Cash Flow1 |
10 428 | 11 717 | 12 875 | 11 691 | 13 282 | 13 192 | 14 625 | 15 138 |
ROE (Net Profit / Equities) |
15,3% | 16,5% | 17,5% | 23,5% | 22,7% | 20,7% | 22,8% | 23,7% |
Shareholders' equity1 |
50 380 | 76 391 | 40 842 | 34 376 | 105 885 | 44 940 | 45 409 | 45 289 |
ROA (Net Profit / Asset) |
5,85% | 9,05% | 8,89% | 6,45% | 10,9% | 7,86% | 8,82% | 9,26% |
Assets1 |
131 601 | 139 321 | 80 393 | 125 215 | 221 201 | 118 638 | 117 160 | 116 097 |
Book Value Per Share2 |
32,0 | 34,0 | 24,5 | 25,1 | 30,3 | 28,9 | 28,8 | 30,2 |
Cash Flow per Share2 |
5,37 | 5,38 | 5,88 | 5,95 | 6,67 | 6,74 | 7,28 | 7,72 |
Capex1 |
1 696 | 1 773 | 2 257 | 1 275 | 1 378 | 1 740 | 1 749 | 1 746 |
Capex / Sales |
3,45% | 3,42% | 4,76% | 2,62% | 2,67% | 3,29% | 3,20% | 3,12% |
Announcement Date |
01/24/2018 | 01/30/2019 | 01/29/2020 | 01/26/2021 | 02/02/2022 | - | - | - |
1 USD in Million 2 USD |
|
| |
|
|
EQT pushes back Galderma IPO plans amid market turmoil - sources |
|
NOVARTIS AG Back to basics |
Capitalization (CHF) |
188 307 222 276 |
Capitalization (USD) |
193 024 747 095 |
Net sales (USD) |
51 626 000 000 |
Number of employees |
110 000 |
Sales / Employee (USD) |
469 327 |
Free-Float |
88,1% |
Free-Float capitalization (CHF) |
165 925 977 153 |
Free-Float capitalization (USD) |
170 082 800 805 |
Avg. Exchange 20 sessions (USD) |
417 662 966 |
Average Daily Capital Traded |
0,22% |
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|